Treatment Options for Attention Deficit Hyperactivity Disorder
Clinical Questions Addressed by the CER
In preparing the report on which this continuing medical education (CME) activity is based, the authors aimed to answer the three Key Questions (KQs) listed below.
KQ 1: Among children younger than 6 years of age with ADHD or disruptive behavior disorder (DBD), what are the effectiveness and adverse event outcomes following treatment?
KQ2: Among people 6 years of age or older with ADHD, what are the effectiveness and adverse event outcomes following 12 months or more of any combination of followup or treatment, including, but not limited to, 12 months or more of continuous treatment?
KQ3: How do a) underlying prevalence of ADHD and b) rates of diagnosis (clinical identification) and treatment for ADHD vary by geography, time period, provider type, and socioeconomic characteristics?
- Charach A, Dashti B, Carson P, et al. Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-Risk Preschoolers; Long-Term Effectiveness in All Ages; and Variability in Prevalence, Diagnosis, and Treatment. Comparative Effectiveness Review No. 44 (Prepared by McMaster University Evidence-based Practice Center under Contract No. MME 2202 290-02-0020). Rockville, MD: Agency for Healthcare Research and Quality; October 2011. AHRQ Publication No. 11(12)-EHC003-EF. Available at www.effectivehealthcare.ahrq.gov/adhdtreatment.cfm.
Your slide tray is being processed.